1. Academic Validation
  2. Myotonic dystrophy protein kinase is critical for nuclear envelope integrity

Myotonic dystrophy protein kinase is critical for nuclear envelope integrity

  • J Biol Chem. 2011 Nov 18;286(46):40296-306. doi: 10.1074/jbc.M111.241455.
Erin B Harmon 1 Michelle L Harmon Tricia D Larsen Jie Yang Joseph W Glasford M Benjamin Perryman
Affiliations

Affiliation

  • 1 Cardiovascular Health Research Center, Sanford Research/USD, Sioux Falls, South Dakota 57104, USA. erin.harmon@sanfordhealth.org
Abstract

Myotonic dystrophy 1 (DM1) is a multisystemic disease caused by a triplet nucleotide repeat expansion in the 3' untranslated region of the gene coding for myotonic dystrophy protein kinase (DMPK). DMPK is a nuclear envelope (NE) protein that promotes myogenic gene expression in skeletal myoblasts. Muscular dystrophy research has revealed the NE to be a key determinant of nuclear structure, gene regulation, and muscle function. To investigate the role of DMPK in NE stability, we analyzed DMPK expression in epithelial and myoblast cells. We found that DMPK localizes to the NE and coimmunoprecipitates with Lamin-A/C. Overexpression of DMPK in HeLa cells or C2C12 myoblasts disrupts Lamin-A/C and Lamin-B1 localization and causes nuclear fragmentation. Depletion of DMPK also disrupts NE lamina, showing that DMPK is required for NE stability. Our data demonstrate for the first time that DMPK is a critical component of the NE. These novel findings suggest that reduced DMPK may contribute to NE instability, a common mechanism of skeletal muscle wasting in muscular dystrophies.

Figures